Expiring in 2041, the patent covers preparation and use of Recce Pharmaceuticals’s (ASX: RCE) synthetic anti-infectives across a range of potential applications, including bacterial and viral ...

A lot of ink has been spilled about the anti-microbial resistance space and why it’s so hard to create a profitable company in it. But that hasn’t stopped some start-ups from making the effort, and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recce Pharmaceuticals secured a Vietnamese Family 4 patent covering the manufacture and use of RECCE® 327 and RECCE® 529. The patent extends protection in Vietnam until 2041 and is the eighth granted ...

The news: Shares in Recce Pharmaceuticals fell in afternoon trade despite the biotech company securing a patent in Vietnam for its flagship anti-infective treatment, extending intellectual property ...

Development and commercialisation of a drug discovery and development business commercialising new Classes of synthetic anti-infectives with spectrum activity designed to address the urgent global ...

Mostly cloudy with a chance of showers and thunderstorms. Highs in the lower to mid 80s. Southwest winds 5 to 15 mph with gusts up to 25 mph. Chance of rain 50 percent. Showers with a chance of ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Jul 20, 2026 1:53 pm - Park Ridge firefighters rescued two dogs from a house fire late Saturday that caused $200,000 in damage to the home.

Park Ridge OK’s one more year with Flock license-plate cameras By Jesse Wright July 9, 2026 at 4:58 p.m.

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. It produces antibiotics that are effective in attacking disease-causing Gram-positive and ...